Genitourinary Pathology
Research and clinical expertise in prostate, bladder, and kidney pathology, including PTEN/ERG profiling in prostate cancer and PD-L1 in urothelial carcinoma.
My genitourinary pathology training at The Johns Hopkins Hospital under Dr. Jonathan Epstein, followed by staff work at the Armed Forces Institute of Pathology, formed the foundation of a long-term research and clinical interest in urologic tumors.
Research lines:
- Prevalence of PTEN loss and ERG expression in a Brazilian prostate cancer cohort
- PD-L1 and interferon gamma expression in BCG-treated urothelial carcinomas of the bladder
- Mesenchymal tumors of the bladder and prostate
- Prostatic carcinomas with neuroendocrine differentiation
Collaborative work:
- Member of the 2019 Genitourinary Pathology Society (GUPS) white paper panel on prostate cancer grading
- Contributor to ISUP and GUPS consensus surveys on prostate cancer reporting practices
- Contributor to WHO Classification of Tumours of the Genitourinary Tract, 2021
Selected publications:
- Epstein et al., Arch Pathol Lab Med 2021 — GUPS White Paper on Prostate Cancer Grading
- Morais et al., Braz J Med Biol Res 2019 — PTEN and ERG in Brazilian prostate cancer
- Távora & Epstein, Am J Surg Pathol 2008 — Ductal adenocarcinoma of the prostate